by admin | Mar 6, 2024 | News & Opinions
By Weill Cornell Medicine – A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation. The results,...
by admin | Mar 5, 2024 | News & Opinions
by Megan Giboney – RegMedNet – The US FDA has granted accelerated approval for AMTAGVI™ (lifileucel), a novel cell therapy for advanced melanoma. This is the first cell therapy to be approved by the FDA for the treatment of a solid tumor. AMTAGVI utilizes...
by admin | Mar 4, 2024 | News & Opinions
By University of California Irvine – Popular Science recently chose Quinton Smith, UC Irvine assistant professor of chemical and biomolecular engineering, as one of its Brilliant 10 scientists “on the cusp of changing the world” for his research on growing...
by admin | Mar 1, 2024 | News & Opinions
By the HSAC TEAM Healthspan Action Coalition (HSAC) is sponsoring The Livelong Summit™ to bring you an exclusive 2-day event featuring some of the greatest minds in medicine and longevity science. Because so many medical professionals have already signed up, we’ve...
by admin | Feb 27, 2024 | News & Opinions
By April Wendling, University of Illinois at Urbana-Champaign – Phys.org – CRISPR/Cas systems have undergone tremendous advancement in the past decade. These precise genome editing tools have applications ranging from transgenic crop development to gene...
by admin | Feb 26, 2024 | News & Opinions
By U. Rochester-URMC – Futuirity – The American Red Cross is experiencing the most critical blood shortage in 20 years. Blood shortages are all too common, but they’re occurring more frequently now than ever before. Contact the Red Cross to find local...
